Abstract
Introduction: Pregabalin is a gamma-aminobutyric acid (GABA) analogue approved for the treatment of neuropathic pain, partial seizure and generalized anxiety disorder. As a GABA analogue, there is a raising concern regarding the abuse potential of this drug.
Case: We present a first case of pregabalin dependence in a 26-year-old woman without a previous history of illicit drug abuse.
Discussion: Physician should be aware about the addictive potential of pregabalin even in patients without a previous history of substance abuse.
Keywords: Bipolar disorder, pregabalin, substance abuse.
Current Drug Safety
Title:Pregabalin Dependence: A Case Report
Volume: 10 Issue: 2
Author(s): Athar Halaby, Sandra Abou Kassm and Wadih J. Naja
Affiliation:
Keywords: Bipolar disorder, pregabalin, substance abuse.
Abstract: Introduction: Pregabalin is a gamma-aminobutyric acid (GABA) analogue approved for the treatment of neuropathic pain, partial seizure and generalized anxiety disorder. As a GABA analogue, there is a raising concern regarding the abuse potential of this drug.
Case: We present a first case of pregabalin dependence in a 26-year-old woman without a previous history of illicit drug abuse.
Discussion: Physician should be aware about the addictive potential of pregabalin even in patients without a previous history of substance abuse.
Export Options
About this article
Cite this article as:
Halaby Athar, Kassm Abou Sandra and Naja J. Wadih, Pregabalin Dependence: A Case Report, Current Drug Safety 2015; 10 (2) . https://dx.doi.org/10.2174/1574886309666141022101956
DOI https://dx.doi.org/10.2174/1574886309666141022101956 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Functional Interference of Dexamethasone on Some Morphine Effects:Hypothesis for the Steroid-Opioid Interaction
Recent Patents on CNS Drug Discovery (Discontinued) Current Development in Encapsulated Cell Therapy for Degenerative Retinopathies
Current Tissue Engineering (Discontinued) Probiotics/Prebiotics in Viral Respiratory Infections: Implication for Emerging Pathogens
Recent Patents on Biotechnology Concise Synthesis of Non-Protein Amino Acid from Natural Product via Schmidt Reaction
Letters in Organic Chemistry A Review of Recent Patents on the ASICs as a Key Drug Target
Recent Patents on Biotechnology Clinical Observation of Electroencephalographic Changes and Risk of Convulsion Occurrence in Children Receiving Neural Precursor Cell Transplantation
CNS & Neurological Disorders - Drug Targets Recent Advances in Oral Pulsatile Drug Delivery
Recent Patents on Drug Delivery & Formulation Cytochrome P450 in Neurological Disease
Current Drug Metabolism Preface [Hot Topic: Rational Drug Design and The Discovery of the 1,2,3-Triazolines as a Unique Class of Anticonvulsants and Antiischemic Agents (Guest Editor: Pankaja K. Kadaba)]
Current Medicinal Chemistry Therapeutic Hypothermia in Brain Injuries and Related Diseases
Recent Patents on Inflammation & Allergy Drug Discovery Bioanalytical Applications of Au Nanoparticles
Recent Patents on Nanotechnology Pharmacology and Drug Discovery for T-Type Calcium Channels
CNS & Neurological Disorders - Drug Targets Use of Intravenous Immunoglobulin in the Treatment of Immune-Mediated Demyelinating Diseases of the Nervous System
Current Pharmaceutical Design Metabotropic Glutamate Receptors in the Control of Neuronal Activity and as Targets for Development of Anti-Epileptogenic Drugs
Current Medicinal Chemistry Clinical Pharmacogenetics and Potential Application in Personalized Medicine
Current Drug Metabolism Mitochondrial Involvement in Psychiatric Illness in Adults
Current Psychiatry Reviews Treatment Options in Alzheimer´s Disease: The GABA Story
Current Pharmaceutical Design Dietary Flavonoids Interaction with CREB-BDNF Pathway: An Unconventional Approach for Comprehensive Management of Epilepsy
Current Neuropharmacology Evaluation of Current Pharmacological Treatment Options in the Management of Rett Syndrome: From the Present to Future Therapeutic Alternatives.
Current Clinical Pharmacology The Development of Medications for Alcohol-Use Disorders Targeting the GABAB Receptor System
Recent Patents on CNS Drug Discovery (Discontinued)